DAEWON PHARMACEUTICAL CO.,LTD

003220 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩7,970.00
+0.00%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

✓Strengths

  • Sales have compounded about 11% a year over five years.
  • Pays a dividend (yield about 2.1%).
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

  • Higher leverage: debt-to-equity of 1.23 is above 1.
  • Thin interest cover: operating profit covers interest only about 0.3 times.
  • Return on equity is on the lower side at -0.5%.
  • Return on capital employed is on the lower side at 0.9%.
  • The company reported a net loss in the latest period.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
1.66

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
0 / 5

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 5 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₩1,708억
Current Price₩ 7,970.00
High / Low₩ 13,670.00 / 0.00
Stock P/E-123.82
Book Value₩ 12,406.70
Dividend Yield2.10%
ROCE0.88%
ROE-0.52%
Debt to Equity1.23
Current Ratio1.19
EPS₩ -64.37
PAT Margin-0.66%
ICR0.29
Compounded Sales Growth
10 Years —
5 Years 11.34%
3 Years —
TTM —
Compounded Profit Growth
10 Years —
5 Years —
3 Years —
TTM —
Stock Price CAGR
10 Years —
5 Years —
3 Years —
1 Year —
Return on Equity
10 Years —
5 Years —
3 Years —
Last Year -0.52%
Educational data only. Not a recommendation to buy, sell or hold any security.